🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalUK Boots vs LloydsPharmacy — anyone have experience? Page 4

UK Boots vs LloydsPharmacy — anyone have experience?

KetoKyle Thu, Apr 4, 2024 at 5:03 PM 61 replies 3,286 viewsPage 4 of 13
newstart_MO
New Member
12
45
Feb 2026
Springfield, MO
Apr 9, 2024 at 10:37 AM#16

Adding the clinical framing, because it changes how the question reads. Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then measure again under the same conditions.

Last edited: Apr 9, 2024 at 4:37 PM
5 5bri_stats, pete_manc_UK, anna.melb_AU and 2 others
Reply Quote Save Share Report
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Apr 10, 2024 at 12:57 AM#17
PharmacoVig_BOS said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

True, with the qualification that this is a self-selected group. The people for whom it did not work post less, and that shapes everything we think we know.

4 4Dr.RaviCardio, jennifer_SEA, tyler_CSCS and 1 other
Reply Quote Save Share Report
FDA_TrackerJim
Senior Member
1,567
7,890
Feb 2024
Rockville, MD
Apr 10, 2024 at 3:16 PM#18
PharmacoVig_BOS said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

Thank you for spelling out the reasoning rather than just the conclusion. Sending this to two other people who asked me the same thing last week.

3 3MikeNYC_runner
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
MASHdoc_SA
Member
456
2,345
Aug 2024
San Antonio, TX
Apr 11, 2024 at 5:35 AM#19

From the other side of the consultation, briefly. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

Last edited: Apr 11, 2024 at 8:35 AM
2 2LabKate, kate.chem
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Apr 11, 2024 at 7:54 PM#20

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful.

Last edited: Apr 11, 2024 at 9:54 PM
30 5PurityPaulOR, MaxMetOK, MounjBrad and 27 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register